HK1074046A1 - Ccr1 antagonists for the treatment of i.a. demyelinating inflammatory disease - Google Patents
Ccr1 antagonists for the treatment of i.a. demyelinating inflammatory diseaseInfo
- Publication number
- HK1074046A1 HK1074046A1 HK05107405A HK05107405A HK1074046A1 HK 1074046 A1 HK1074046 A1 HK 1074046A1 HK 05107405 A HK05107405 A HK 05107405A HK 05107405 A HK05107405 A HK 05107405A HK 1074046 A1 HK1074046 A1 HK 1074046A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- treatment
- inflammatory disease
- compounds
- ccr1 antagonists
- demyelinating inflammatory
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HK06108230A HK1086011A1 (en) | 2002-11-13 | 2005-08-23 | Ccr1 antagonists for the treatment of i.a demyelinating inflammatory disease |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42594702P | 2002-11-13 | 2002-11-13 | |
PCT/US2003/035817 WO2004043965A1 (en) | 2002-11-13 | 2003-11-12 | Ccr1 antagonists for the treatment of i.a. demyelinating inflammatory disease |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1074046A1 true HK1074046A1 (en) | 2005-10-28 |
Family
ID=32313083
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK06108230A HK1086011A1 (en) | 2002-11-13 | 2005-08-23 | Ccr1 antagonists for the treatment of i.a demyelinating inflammatory disease |
HK05107405A HK1074046A1 (en) | 2002-11-13 | 2005-08-23 | Ccr1 antagonists for the treatment of i.a. demyelinating inflammatory disease |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK06108230A HK1086011A1 (en) | 2002-11-13 | 2005-08-23 | Ccr1 antagonists for the treatment of i.a demyelinating inflammatory disease |
Country Status (25)
Country | Link |
---|---|
US (7) | US20040106639A1 (de) |
EP (2) | EP1669356B1 (de) |
JP (1) | JP4644491B2 (de) |
KR (1) | KR101109348B1 (de) |
CN (1) | CN100343257C (de) |
AR (1) | AR041942A1 (de) |
AT (2) | ATE468340T1 (de) |
AU (2) | AU2003291452A1 (de) |
BR (1) | BR0316261A (de) |
CA (1) | CA2505874C (de) |
CY (1) | CY1107985T1 (de) |
DE (2) | DE60305063T2 (de) |
DK (1) | DK1562954T3 (de) |
EA (1) | EA007748B1 (de) |
ES (2) | ES2346337T3 (de) |
HK (2) | HK1086011A1 (de) |
IL (2) | IL168384A (de) |
MX (1) | MXPA05005105A (de) |
NO (1) | NO331855B1 (de) |
PL (1) | PL211022B1 (de) |
PT (1) | PT1562954E (de) |
SI (1) | SI1562954T1 (de) |
TW (1) | TWI291467B (de) |
WO (1) | WO2004043965A1 (de) |
ZA (2) | ZA200504144B (de) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7271176B2 (en) * | 1998-09-04 | 2007-09-18 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use thereof |
US7541365B2 (en) * | 2001-11-21 | 2009-06-02 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
TWI291467B (en) * | 2002-11-13 | 2007-12-21 | Millennium Pharm Inc | CCR1 antagonists and methods of use therefor |
US7838522B2 (en) | 2004-11-17 | 2010-11-23 | Ares Trading S.A. | Benzothiazole formulations and use thereof |
WO2006066200A2 (en) * | 2004-12-17 | 2006-06-22 | Millennium Pharmaceuticals, Inc. | Solid forms of a chemokine receptor antagonist and methods of use thereof |
CN101124213B (zh) | 2004-12-21 | 2012-02-01 | 默克雪兰诺有限公司 | 磺酰氨基环状衍生物及其应用 |
WO2006079653A1 (en) | 2005-01-31 | 2006-08-03 | Laboratoires Serono S.A. | N-hydroxyamide derivatives and use thereof |
BRPI0613042A2 (pt) | 2005-07-15 | 2010-12-14 | Serono Lab | inibidores de jnk para o tratamento de endometriose |
KR20080044836A (ko) | 2005-07-15 | 2008-05-21 | 라보라뚜와르 세로노 에스. 에이. | 자궁내막증 치료용 jnk 억제제 |
KR20080050591A (ko) | 2005-09-01 | 2008-06-09 | 아레스 트레이딩 에스.에이. | 시신경염 치료 |
US7601844B2 (en) | 2006-01-27 | 2009-10-13 | Bristol-Myers Squibb Company | Piperidinyl derivatives as modulators of chemokine receptor activity |
CN101489556A (zh) * | 2006-07-14 | 2009-07-22 | 伊莱利利公司 | 糖皮质激素受体调节剂及使用方法 |
CN101808991A (zh) * | 2007-07-24 | 2010-08-18 | 百时美施贵宝公司 | 作为趋化因子受体活性调节剂的哌啶基衍生物 |
WO2009082526A2 (en) * | 2007-10-05 | 2009-07-02 | Pharmacopeia, Inc. | Ortho pyrrolidine, benzyl-substituted heterocycle ccr1 antagonists for autoimmune diseases & inflammation |
JP2011505364A (ja) * | 2007-11-30 | 2011-02-24 | ミレニアム・ファーマシューティカルズ・インコーポレイテッド | TMEDAを用いた5−シクロプロピル−5,11−ジヒドロ[1]ベンゾオキセピノ[3,4−b]−ピリジン−5−オールの製造方法 |
US20090286823A1 (en) * | 2007-12-17 | 2009-11-19 | Millennium Pharmaceuticals Inc. | CCR1 Inhibitors useful for the treatment of multiple myeloma and other disorders |
KR101237296B1 (ko) | 2008-01-11 | 2013-03-04 | 일라이 릴리 앤드 캄파니 | 류마티스성 관절염의 치료를 위한 글루코코르티코이드 수용체 조절제로서의 (E)-N-{3-[1-(8-플루오로-11H-10-옥사-1-아자-디벤조[a,d]시클로헵텐-5-일리덴)-프로필]-페닐}-메탄술폰아미드 |
TWI433838B (zh) | 2008-06-25 | 2014-04-11 | 必治妥美雅史谷比公司 | 作為趨化因子受體活性調節劑之六氫吡啶衍生物 |
US20140329809A1 (en) | 2011-10-28 | 2014-11-06 | Galderma Research & Development | New leukocyte infiltrate markers for rosacea and uses thereof |
Family Cites Families (104)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US377729A (en) * | 1888-02-07 | Half to phillips | ||
DD80449A (de) | ||||
DE80449C (de) | ||||
GB1003292A (en) | 1960-12-08 | 1965-09-02 | Sandoz Ag | Improvements in or relating to 4-azathiaxanthene derivatives |
NL279409A (de) | 1961-06-08 | |||
CH416624A (de) | 1962-10-23 | 1966-07-15 | Sandoz Ag | Verfahren zur Herstellung von neuen heterocyclischen Verbindungen |
NL132137C (de) | 1963-04-24 | |||
FR88751E (de) | 1963-07-09 | 1967-06-07 | ||
GB1085406A (en) | 1963-10-14 | 1967-10-04 | Pfizer & Co C | Aminoalkylphosphorus compounds, preparation thereof and reaction products with ketones |
FR145F (de) | 1964-06-01 | |||
CH421138A (de) | 1965-11-04 | 1966-09-30 | Wander Ag Dr A | Verfahren zur Herstellung von Thioxanthenderivaten |
US3409621A (en) * | 1966-04-01 | 1968-11-05 | Schering Corp | Piperazino-aza-dibenzo-[a, d]-cycloheptenes |
US3625974A (en) | 1967-04-28 | 1971-12-07 | Fujisawa Pharmaceutical Co | Dibenzothiazepine derivatives |
GB1206216A (en) | 1967-07-18 | 1970-09-23 | Pfizer & Co C | Aminopropylidene dibenzoxepine tranquilizers |
NL6905642A (de) | 1968-04-12 | 1969-10-14 | ||
JPS4830064B1 (de) | 1968-12-23 | 1973-09-17 | ||
JPS4840356Y1 (de) | 1969-12-22 | 1973-11-27 | ||
US3770729A (en) * | 1970-12-22 | 1973-11-06 | Yoshitomi Pharmaceutical | N substituted piperidine compounds |
GB1330966A (en) | 1970-12-22 | 1973-09-19 | Yoshitomi Pharmaceutical | N-substituted piperidine compounds methods for their production and pharmaceutical compositions containing them |
JPS5146625Y2 (de) | 1971-03-24 | 1976-11-10 | ||
GB1347935A (en) | 1971-04-10 | 1974-02-27 | Yoshitomi Pharmaceutical | Piperazine derivatives methods for their production and phar maceutical compositions containing them |
CA1010870A (en) * | 1972-12-08 | 1977-05-24 | Niels Lassen | Thiaxanthene derivative and method |
US4250176A (en) * | 1976-12-21 | 1981-02-10 | Janssen Pharmaceutica N.V. | Piperazine derivatives |
US4335122A (en) * | 1981-03-18 | 1982-06-15 | Hoechst-Roussel Pharmaceuticals Inc. | Dihydro-dibenzoxepines-thiepines and -morphanthridones, compositions and use |
DE3326641A1 (de) | 1982-07-27 | 1984-02-02 | Basf Ag, 6700 Ludwigshafen | 5,6-dihydro-11-h-morphantridin-6-one, ihre herstellung und diese enthaltende arzneimittel |
US4547496A (en) * | 1983-06-24 | 1985-10-15 | Kyowa Hakko Kogyo Co., Ltd. | Antiulcer [1] benzepino[3,4-b]pyridine and compositions |
ES8502099A1 (es) | 1983-08-02 | 1984-12-16 | Espanola Farma Therapeut | Procedimiento de obtencion de nuevos compuestos derivados de la difenil-metilen-etilamina. |
DE3402060A1 (de) * | 1984-01-21 | 1985-08-01 | Dr. Karl Thomae Gmbh, 7950 Biberach | Substituierte 5,11-dihydro-6h-dibenz(b,e)azepin-6-one, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
CS236550B1 (cs) | 1984-02-02 | 1985-05-15 | Miroslav Protiva | Způsob přípravy esterů piperazinoalkanolů dibenzo(b,e)thiepinové řady a jejich solí s kyselinou maleinovou |
CS236549B1 (cs) | 1984-02-02 | 1985-05-15 | Miroslav Protiva | Piperazinoalkanoly dibenzo(b,e)thiepinové řady a jejich soli s kyselinou maleinovou |
CS240698B1 (cs) | 1984-10-12 | 1986-02-13 | Miroslav Protiva | Substituované ll-(piperidinoalkyl)-6,ll-dihydrodibenzo (b,e)thiepin-ll-karbonitrily |
JPH0665664B2 (ja) | 1985-01-18 | 1994-08-24 | 大塚製薬株式会社 | モルフアントリジン誘導体 |
SE8500273D0 (sv) * | 1985-01-22 | 1985-01-22 | Leo Ab | Nya tricykliska foreningar, kompositioner innehallande sadana foreningar, framstellningsforfaranden och behandlingsmetoder |
JPS6310784A (ja) | 1986-03-03 | 1988-01-18 | Kyowa Hakko Kogyo Co Ltd | 抗アレルギー剤 |
WO1988000049A1 (en) | 1986-06-26 | 1988-01-14 | Kyowa Hakko Kogyo Co., Ltd. | Antiarrhythmic agent |
US5089496A (en) * | 1986-10-31 | 1992-02-18 | Schering Corporation | Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies |
IT8721978A0 (it) | 1987-09-21 | 1987-09-21 | Angeli Inst Spa | Nuovi derivati ammidinici triciclici. |
US4882351A (en) * | 1987-10-14 | 1989-11-21 | Roussel Uclaf | Tricyclic compounds |
US4994463A (en) * | 1987-12-14 | 1991-02-19 | Kyowa Hakko Kogyo Co., Ltd. | Tricyclic thromboxane A2 antagonists |
NZ228888A (en) | 1988-04-28 | 1991-12-23 | Schering Corp | Derivatives of piperidine, piperidylidene and piperazine and pharmaceutical compositions |
US5242931A (en) * | 1988-06-09 | 1993-09-07 | Kyowa Hakko Kogyo Co., Ltd. | Tricyclic compounds as TXA2 antagonists |
US4999363A (en) * | 1988-06-09 | 1991-03-12 | Kyowa Hakko Kogyo Co., Ltd. | Tricyclic compounds |
DE3827093A1 (de) | 1988-08-10 | 1990-02-15 | Nattermann A & Cie | Verfahren zur herstellung von hochreinem ebselen |
DE3838912A1 (de) * | 1988-11-17 | 1990-05-23 | Thomae Gmbh Dr K | Mittel zur behandlung von akuten und chronischen obstruktiven atemwegserkrankungen |
JPH0694464B2 (ja) * | 1991-01-23 | 1994-11-24 | 協和醗酵工業株式会社 | 三環式化合物およびその中間体 |
CA2062587A1 (en) * | 1991-03-11 | 1992-09-12 | Toshiaki Kumazawa | Indole derivatives |
WO1992016226A1 (en) | 1991-03-19 | 1992-10-01 | Smithkline Beecham Corporation | Il-1 inhibitors |
AU2028892A (en) | 1991-05-23 | 1992-12-30 | Schering Corporation | Novel benzopyrido piperidylidene compounds, compositions, methods of manufacture and methods of use |
WO1993002081A1 (en) | 1991-07-23 | 1993-02-04 | Schering Corporation | Novel benzopyrido piperylidene compounds, compositions, methods of manufacture and methods of use |
US5378701A (en) * | 1991-12-27 | 1995-01-03 | Kyowa Hakko Kogyo | Tricyclic compounds |
US5679703A (en) * | 1992-09-16 | 1997-10-21 | Kyowa Hakko Kogyo, Co., Ltd. | Tricyclic compounds having ACAT inhibiting activity |
EP0669979B1 (de) | 1992-11-10 | 2005-10-12 | Genentech, Inc. | C-c ckr-1, ein c-c chemokin rezeptor |
US5538986A (en) * | 1993-12-06 | 1996-07-23 | Schering Corporation | Tricyclic derivatives, compositions and methods of use |
MY113463A (en) * | 1994-01-04 | 2002-03-30 | Novo Nordisk As | Novel heterocyclic compounds |
WO1996031469A1 (en) | 1995-04-07 | 1996-10-10 | Novo Nordisk A/S | N-substituted azaheterocyclic carboxylic acids and esters thereof |
AU5271096A (en) | 1995-04-07 | 1996-10-23 | Novo Nordisk A/S | Novel heterocyclic compounds |
US5801175A (en) * | 1995-04-07 | 1998-09-01 | Schering Corporation | Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
US5712280A (en) | 1995-04-07 | 1998-01-27 | Schering Corporation | Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
UA54385C2 (uk) * | 1995-04-07 | 2003-03-17 | Ново Нордіск А/С | N-заміщені азагетероциклічні карбонові кислоти та їх ефіри, спосіб їх одержання, фармацевтична композиція та спосіб лікування |
JPH0940662A (ja) | 1995-05-24 | 1997-02-10 | Kyowa Hakko Kogyo Co Ltd | 三環式化合物 |
CA2231773A1 (en) * | 1995-09-13 | 1997-03-20 | Shigeru Aono | Phenylpiperidine derivative |
WO1997024325A1 (en) | 1995-12-28 | 1997-07-10 | Takeda Chemical Industries, Ltd. | DIPHENYLMETHANE DERIVATIVES AS MIP-1α/RANTES RECEPTOR ANTAGONISTS |
DE29602088U1 (de) | 1996-02-07 | 1996-04-04 | Buemach Engineering Internatio | Verschraubbarer druckmittelbetätigter Arbeitszylinder mit Verschlußteilen zur Kopplung des Zylinderrohres |
DE69709647T2 (de) | 1996-05-20 | 2002-11-07 | Teijin Ltd | Cyclischer diarylalkyl diaminederivate als antogoniste von chemokinerezeptoren |
US6323206B1 (en) * | 1996-07-12 | 2001-11-27 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
EP0920306A2 (de) | 1996-07-12 | 1999-06-09 | Leukosite, Inc. | Chemokinrezeptor antagoniste und verfahren zu deren herstellung |
US6140338A (en) | 1996-07-29 | 2000-10-31 | Banyu Pharmaceutical, Co., Ltd. | Chemokine receptor antagonists |
EP0927178B1 (de) | 1996-09-13 | 2002-02-27 | Schering Corporation | Tricyclische verbindungen zur inhibierung der g-protein funktion und für die behandlung von proliferativen erkrankungen |
PL332253A1 (en) | 1996-09-13 | 1999-08-30 | Schering Corp | Derivatives of subtituted benzocycloheptapyridine useful in inhibiting proteinous farnesil transferase |
CA2265763A1 (en) | 1996-09-13 | 1998-03-19 | Alan B. Cooper | Tricyclic piperidinyl compounds useful as inhibitors of farnesyl-protein transferase |
CZ84399A3 (cs) | 1996-09-13 | 1999-11-17 | Schering Corporation | Tricyklické inhibitory farnesyl protein transferázy |
KR20000036111A (ko) | 1996-09-13 | 2000-06-26 | 둘락 노먼 씨. | 파네실 단백질 트랜스페라제 억제제인 트리사이클릭 항종양성화합물 |
JP2001500506A (ja) | 1996-09-13 | 2001-01-16 | シェーリング コーポレイション | ファルネシルタンパク質トランスフェラーゼのインヒビターとして有用な置換ベンゾシクロヘプタピリジン |
JP2001500505A (ja) | 1996-09-13 | 2001-01-16 | シェーリング コーポレイション | Fptインヒビターとして有用な三環式化合物 |
CZ114199A3 (cs) | 1996-10-04 | 1999-09-15 | Novo Nordisk A/S | N-Substituované azaheterocyklické sloučeniny |
AU740662B2 (en) | 1996-10-04 | 2001-11-08 | Novo Nordisk A/S | 1,4-disubstituted piperazines |
ZA978792B (en) | 1996-10-04 | 1998-04-06 | Novo Nordisk As | N-substituted azaheterocyclic compounds. |
WO1998025604A1 (en) | 1996-12-13 | 1998-06-18 | Merck & Co., Inc. | Spiro-substituted azacycles as modulators of chemokine receptor activity |
WO1998025617A1 (en) | 1996-12-13 | 1998-06-18 | Merck & Co., Inc. | Substituted aryl piperazines as modulators of chemokine receptor activity |
AU5803398A (en) | 1996-12-13 | 1998-07-03 | Merck & Co., Inc. | Spiro-substituted azacycles as modulators of chemokine receptor activity |
AU5812498A (en) | 1996-12-20 | 1998-07-17 | Merck & Co., Inc. | Substituted aminoquinolines as modulators of chemokine receptor activity |
US5919776A (en) * | 1996-12-20 | 1999-07-06 | Merck & Co., Inc. | Substituted aminoquinolines as modulators of chemokine receptor activity |
WO1998043638A1 (fr) | 1997-03-27 | 1998-10-08 | Kyowa Hakko Kogyo Co., Ltd. | Agent therapeutique pour maladies auto-immunes |
US5877177A (en) * | 1997-06-17 | 1999-03-02 | Schering Corporation | Carboxy piperidylacetamide tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
US6040318A (en) | 1997-06-25 | 2000-03-21 | Novo Nordisk A/S | Tricycle substituted with azaheterocyclic carboxylic acids |
JP2002515914A (ja) | 1997-06-25 | 2002-05-28 | ノボ ノルディスク アクティーゼルスカブ | 新規へテロ環式化合物 |
US6048856A (en) * | 1997-12-17 | 2000-04-11 | Novo Nordisk A/S | Heterocyclic compounds |
US6433165B1 (en) * | 1998-01-21 | 2002-08-13 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
US6613905B1 (en) * | 1998-01-21 | 2003-09-02 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
US6509346B2 (en) * | 1998-01-21 | 2003-01-21 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
AU2331999A (en) * | 1998-01-21 | 1999-08-09 | Kyowa Hakko Kogyo Co. Ltd. | Chemokine receptor antagonists and methods of use therefor |
US6503926B2 (en) * | 1998-09-04 | 2003-01-07 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
US20020169155A1 (en) * | 1998-09-04 | 2002-11-14 | Millennium Pharmaceuticals, Inc. | Chemokine receptor anagonists and methods of use therefor |
WO2000014089A1 (en) | 1998-09-04 | 2000-03-16 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
US6288083B1 (en) * | 1998-09-04 | 2001-09-11 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
MXPA04004826A (es) | 1998-09-04 | 2004-08-11 | Millenium Pharmaceuticals Inc | Antagonista del receptor de quimioquinas y metodos para su uso. |
US7271176B2 (en) * | 1998-09-04 | 2007-09-18 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use thereof |
EP1135129A1 (de) | 1998-12-02 | 2001-09-26 | Novo Nordisk A/S | Verwendung von n-substituierten azaheterocyclischer verbindungen zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von angiogenese-relatierter zustanden |
AU6499100A (en) | 1999-07-28 | 2001-02-19 | Kyowa Hakko Kogyo Co. Ltd. | Chemokine receptor antagonists and methods of use therefor |
AU6503900A (en) * | 1999-07-28 | 2001-02-19 | Kyowa Hakko Kogyo Co. Ltd. | Chemokine receptor antagonists and methods of use therefor |
EP1448566B3 (de) * | 2001-11-21 | 2009-04-08 | Millennium Pharmaceuticals, Inc. | Chemokine rezeptor antagonisten und methoden zu deren anwendung |
TWI291467B (en) | 2002-11-13 | 2007-12-21 | Millennium Pharm Inc | CCR1 antagonists and methods of use therefor |
CN100524575C (zh) | 2005-04-20 | 2009-08-05 | 三菱电机株式会社 | 过电流继电器 |
JP4715952B2 (ja) | 2009-02-18 | 2011-07-06 | 村田機械株式会社 | フロッグレッグ型移載装置 |
-
2003
- 2003-11-11 TW TW92131488A patent/TWI291467B/zh not_active IP Right Cessation
- 2003-11-12 EP EP20060004508 patent/EP1669356B1/de not_active Expired - Lifetime
- 2003-11-12 US US10/706,835 patent/US20040106639A1/en not_active Abandoned
- 2003-11-12 AT AT06004508T patent/ATE468340T1/de not_active IP Right Cessation
- 2003-11-12 EP EP20030768852 patent/EP1562954B1/de not_active Expired - Lifetime
- 2003-11-12 AU AU2003291452A patent/AU2003291452A1/en not_active Abandoned
- 2003-11-12 DK DK03768852T patent/DK1562954T3/da active
- 2003-11-12 WO PCT/US2003/035817 patent/WO2004043965A1/en active Application Filing
- 2003-11-12 ES ES06004508T patent/ES2346337T3/es not_active Expired - Lifetime
- 2003-11-12 JP JP2004552003A patent/JP4644491B2/ja not_active Expired - Fee Related
- 2003-11-12 EA EA200500803A patent/EA007748B1/ru not_active IP Right Cessation
- 2003-11-12 KR KR1020057008518A patent/KR101109348B1/ko not_active IP Right Cessation
- 2003-11-12 SI SI200330325T patent/SI1562954T1/sl unknown
- 2003-11-12 DE DE2003605063 patent/DE60305063T2/de not_active Expired - Lifetime
- 2003-11-12 CA CA 2505874 patent/CA2505874C/en not_active Expired - Fee Related
- 2003-11-12 CN CNB2003801086866A patent/CN100343257C/zh not_active Expired - Fee Related
- 2003-11-12 BR BR0316261A patent/BR0316261A/pt not_active Application Discontinuation
- 2003-11-12 ES ES03768852T patent/ES2261979T3/es not_active Expired - Lifetime
- 2003-11-12 AR ARP030104145 patent/AR041942A1/es active IP Right Grant
- 2003-11-12 DE DE60332663T patent/DE60332663D1/de not_active Expired - Lifetime
- 2003-11-12 MX MXPA05005105A patent/MXPA05005105A/es active IP Right Grant
- 2003-11-12 AT AT03768852T patent/ATE325124T1/de active
- 2003-11-12 PL PL377715A patent/PL211022B1/pl unknown
- 2003-11-12 PT PT03768852T patent/PT1562954E/pt unknown
-
2005
- 2005-05-04 IL IL168384A patent/IL168384A/en not_active IP Right Cessation
- 2005-05-10 NO NO20052272A patent/NO331855B1/no not_active IP Right Cessation
- 2005-05-23 ZA ZA200504144A patent/ZA200504144B/en unknown
- 2005-08-16 US US11/204,930 patent/US20050288319A1/en not_active Abandoned
- 2005-08-23 HK HK06108230A patent/HK1086011A1/xx not_active IP Right Cessation
- 2005-08-23 HK HK05107405A patent/HK1074046A1/xx not_active IP Right Cessation
-
2006
- 2006-07-21 CY CY061101015T patent/CY1107985T1/el unknown
- 2006-09-20 ZA ZA2006/07868A patent/ZA200607868B/en unknown
-
2007
- 2007-09-13 US US11/900,744 patent/US7732459B2/en not_active Expired - Fee Related
-
2008
- 2008-07-03 AU AU2008202965A patent/AU2008202965B2/en not_active Ceased
-
2010
- 2010-04-22 US US12/765,070 patent/US7977350B2/en not_active Expired - Fee Related
- 2010-12-16 IL IL210046A patent/IL210046A/en active IP Right Grant
-
2011
- 2011-06-02 US US13/151,701 patent/US8394817B2/en not_active Expired - Fee Related
-
2013
- 2013-01-22 US US13/746,688 patent/US20130289063A1/en not_active Abandoned
-
2014
- 2014-02-04 US US14/172,398 patent/US9334283B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1086011A1 (en) | Ccr1 antagonists for the treatment of i.a demyelinating inflammatory disease | |
AP2004003069A0 (en) | 3-beta-d-ribofuranosynthiazolo [4-5-d] pyridimine nucleosides and uses thereof. | |
IL173032A0 (en) | Pyridazine derivatives and their use as therapeutic agents | |
MXPA05002420A (es) | Compuestos de tiazol para el tratamiento de trastornos neurodegenerativos. | |
BR0314052A (pt) | Imidazolpiridinas e métodos para sua fabricação e uso | |
DE60216830D1 (de) | Pharmazeutische Zusammensetzungen zur Behandlung von Störungen des ZNS oder anderen Erkrankungen | |
AU5584901A (en) | Use of cyclic gmp-specific phosphodiesterase inhibitors for treatment of parkinson's disease | |
ATE375341T1 (de) | Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen | |
TNSN04165A1 (en) | Substituted hydroxyethylamines | |
DE602004030222D1 (de) | 2-oxo-1,3,5-perhydrotriazapinderivate, die sich zur behandlung von hyperproliferativen, angiogenen und entzündlichen erkrankungen eignen | |
MXPA03011484A (es) | Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades. | |
BG106095A (en) | Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics | |
TW200635588A (en) | 3,5-disubstituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereof | |
HRP20080175T3 (en) | Substituted 2-aminotetralines for the preventive treatment of parkinson's disease | |
MXPA04000793A (es) | Novedoso metodo terapeutico. | |
WO2003048164A3 (en) | Adenosine a2a receptor antagonists | |
GB0112348D0 (en) | Compounds | |
TNSN06403A1 (en) | 3-B-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF | |
IL162515A0 (en) | Substituted diketopiperazines as oxytocin antagonists | |
CY1119257T1 (el) | Θεραπεια του νευροπαθητικου πονου με ανταγωνιστες υποδοχεα δεξτρομεθορφανης n-meθυλ-d-ασπαρτικων (nmda) | |
MXPA03011702A (es) | Composicion que comprende un inhibidor de fosodiesterasa 4 y un antagonista de receptor h1 y el uso de los mismos para la elaboracion de un medicamento para el tratamiento de enfermedades respiratorias. | |
ATE366107T1 (de) | Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen | |
CA2534634A1 (en) | Azolidinecarbonitriles and their use as dpp-iv inhibitors | |
ATE285773T1 (de) | Pharmazeutische zusammensetzungen zur behandlung von neurologischen krankheiten | |
EA200100876A2 (ru) | Фармацевтическая композиция для предупреждения или лечения заболевания, связанного с избыточным продуцированием il-12 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CHRG | Changes in the register |
Free format text: ADDITION OF INVENTOR: GHOSH, SHOMIR |
|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20151112 |